Hybio Pharmaceutical(300199.SZ): Aselegine Injection approved for listing, used to improve blood sugar control in type 2 diabetes patients.

Hybio Pharmaceutical (300199.SZ) announcement, recently, the company received the "Drug Registration Certificate" issued by the National Medical Products Administration, and the company's "exenatide injection" obtained drug registration approval. It is reported that exenatide is a glucagon-like peptide-1 (GLP-1) analog used to improve blood sugar control in patients with type 2 diabetes, suitable for patients who do not have adequate blood sugar control with metformin alone, sulfonylureas alone, or a combination of metformin and sulfonylureas.